Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.
about
Gemcitabine, navelbine, and doxorubicin as treatment for patients with refractory or relapsed T-cell lymphomaThe DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
P2860
Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@ast
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@en
type
label
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@ast
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@en
prefLabel
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@ast
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@en
P2093
P2860
P1433
P1476
Promising long-term outcome of ...... essive non-Hodgkin's lymphoma.
@en
P2093
Hui-Qiang Huang
Qi-Chun Cai
Qing-Qing Cai
Xiao-Xiao Wang
Ze-Xiao Lin
P2860
P2888
P356
10.1007/S12032-012-0350-5
P577
2013-01-18T00:00:00Z
P6179
1031547844